Neogenomics Inc (NEO) 9.15 $NEO NeoGenomics Schedules

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 11:07 PM

Neogenomics Inc (NEO) 9.15 $NEO

NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016
PR Newswire - Tue Jul 05, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its second quarter 2016 financial results on Tuesday July 26, 2016.
NEO: 9.15 (+0.99)

Fate Therapeutics (FATE) Catches Eye: Stock Jumps 19.1%
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:25AM CDT
Fate Therapeutics, Inc. (FATE) moved big last session, as its shares jumped over 19% on the day.
FATE: 1.77 (-0.01), NEO: 9.15 (+0.99)

Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:30AM CDT
Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
GKOS: 29.24 (+0.28), NEO: 9.15 (+0.99), NCOM: 23.99 (+0.51), AHS: 42.68 (+1.33)

5 Great Growth Stocks To Buy Now
Brian Bolan - ZACKS - Fri Jun 17, 12:57PM CDT
5 Great Growth Stocks To Buy Now
GKOS: 29.24 (+0.28), NEO: 9.15 (+0.99), NCOM: 23.99 (+0.51), AHS: 42.68 (+1.33), NMIH: 5.63 (+0.19)

Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 25.64 (+0.83), UNFI: 48.84 (+1.40), NEO: 9.15 (+0.99), BWP: 17.37 (+0.18), WTW: 11.89 (+0.39)

Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 25.64 (+0.83), UNFI: 48.84 (+1.40), NEO: 9.15 (+0.99), BWP: 17.37 (+0.18), WTW: 11.89 (+0.39)

Neogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Neogenomics Inc. (NEO) has been struggling lately, but the selling pressure may be coming to an end soon
NEO: 9.15 (+0.99)

Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 185.13 (-3.31), NEO: 9.15 (+0.99), CVGI: 4.52 (-0.01)

Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 185.13 (-3.31), NEO: 9.15 (+0.99), CVGI: 4.52 (-0.01)

Bet on These 5 Liquid Stocks for Fat Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:23PM CDT
An efficient company with a favorable liquidity level may prove to be a profitable addition to one's portfolio.
NEO: 9.15 (+0.99), SLAB: 49.54 (+2.04), NTGR: 49.07 (+1.25), LPLA: 22.71 (+0.30), AMPH: 16.80 (+0.14)

The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
CSGP: 221.54 (+4.55), AMSF: 60.89 (+0.70), NEO: 9.15 (+0.99), HIIQ: 4.07 (-0.07), AHS: 42.68 (+1.33)

7 Stocks with Recent Price Strength to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:24AM CDT
Stocks that have recently seen price strength have high chances of carrying the momentum forward.
AMSF: 60.89 (+0.70), NEO: 9.15 (+0.99), HIIQ: 4.07 (-0.07), AHS: 42.68 (+1.33), COHR: 93.01 (+2.60), NANO: 20.89 (+0.64)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 81.45 (+0.59), ANIP: 56.51 (-1.61), NEO: 9.15 (+0.99), RTRX: 18.65 (+0.35)

Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:42AM CDT
Neogenomics (NEO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
NEO: 9.15 (+0.99)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 81.45 (+0.59), HSKA: 43.52 (+2.33), ANIP: 56.51 (-1.61), NEO: 9.15 (+0.99)

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
PR Newswire - Wed Apr 27, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter of 2016.
NEO: 9.15 (+0.99)

Investor Calendar Invites You to the NeoGenomics First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:05PM CDT
FORT MYERS, FL / ACCESSWIRE / April 26, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 11:00 AM Eastern Time.
NEO: 9.15 (+0.99)

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016
PR Newswire - Mon Apr 11, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its first quarter 2016 financial results on Wednesday April 27, 2016.
NEO: 9.15 (+0.99)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

University of Phoenix Unveils Credit for Prior Learning Advantages

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Cowfest 2026 Delighted by Frederick's Flying Cows

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Empire Steak House Expands to Delray Beach

Steakhouse Kings Bring New York Flavors to Florida When you're talking about steak, the Empire Steak House name carries some serious heft. This isn't just another restaurant chain cashing in on prime cuts; it's a family legacy over 21 years in the making. The Sinanaj Brothers, who honed their skills at Peter Luger in New York, are moving their empire south, landing a...

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Parents Nationwide Rally for Youth Online Safety Imperative

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Aberdeen's Reverse Split: What Investors Need to Know

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...